Evidence map›Paper›PMID 38787374›Full record

ArticleeLife2024

A chemically induced attenuated strain of

Swagata Bose, Satya Ranjan Sahu, Abinash Dutta, Narottam Acharya

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Swagata BoseDepartment of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar, India.
Satya Ranjan SahuDepartment of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar, India.
Abinash DuttaDepartment of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar, India.
Narottam AcharyaDepartment of Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar, India.ORCID https://orcid.org/0000-0001-8858-5418

Funding

Department of Biotechnology, Ministry of Science and Technology, India BT/PR32817/MED/29/1495/2020
6 · The paper itself

Abstract

Despite current antifungal therapy, invasive candidiasis causes >40% mortality in immunocompromised individuals. Therefore, developing an antifungal vaccine is a priority. Here, we could for the first time successfully attenuate the virulence of

Indexed as

Candida albicansCandidiasisAnimalsBiofilmsCytokinesDisease Models, AnimalFemaleFungal VaccinesMiceVirulenceCytokinesFungal VaccinesattenuationCandidacandida albicansCandida albicanscandidiasisCytokinesEDTAinfectious diseasemetal chelating agentsmicemicrobiologyWhole-cell vaccine

Identifiers

PMID38787374
PMCPMC11126311

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.